Medical Treatment of Nocturia in Men with Lower Urinary Tract Symptoms: Systematic Review by the European Association of Urology Guidelines Panel for Male Lower Urinary Tract Symptoms.

[1]  K. Yoshimura,et al.  Nocturia: Current Levels of Evidence and Recommendations From the International Consultation on Male Lower Urinary Tract Symptoms. , 2015, Urology.

[2]  Abul-fotouh Ahmed,et al.  The impact of adding low-dose oral desmopressin therapy to tamsulosin therapy for treatment of nocturia owing to benign prostatic hyperplasia , 2015, World Journal of Urology.

[3]  N. Masumori,et al.  A randomized controlled study of the efficacy of tamsulosin monotherapy and its combination with mirabegron for overactive bladder induced by benign prostatic obstruction. , 2015, The Journal of urology.

[4]  W. So,et al.  Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: A randomized controlled trial , 2015, Korean journal of urology.

[5]  P. Hoebeke,et al.  Diagnosing the pathophysiologic mechanisms of nocturnal polyuria. , 2015, European urology.

[6]  M. Drake.  Should nocturia not be called a lower urinary tract symptom? , 2015, European urology.

[7]  Seung-June Oh,et al.  Effect of Combined Systematized Behavioral Modification Education Program With Desmopressin in Patients With Nocturia: A Prospective, Multicenter, Randomized, and Parallel Study , 2014, International neurourology journal.

[8]  C. Roehrborn,et al.  Impact of dutasteride on nocturia in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): a pooled analysis of three phase III studies , 2014, World Journal of Urology.

[9]  C. Roehrborn,et al.  Nocturia improvement in the combination of Avodart® and tamsulosin (CombAT) study , 2014, World Journal of Urology.

[10]  O. Yokoyama,et al.  Efficacy of fesoterodine on nocturia and quality of sleep in Asian patients with overactive bladder. , 2014, Urology.

[11]  D. Cox,et al.  Effects of tadalafil on nighttime voiding (nocturia) in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a post hoc analysis of pooled data from four randomized, placebo-controlled clinical studies , 2014, World Journal of Urology.

[12]  A. Eisenhardt,et al.  Consistent and significant improvement of nighttime voiding frequency (nocturia) with silodosin in men with LUTS suggestive of BPH: pooled analysis of three randomized, placebo-controlled, double-blind phase III studies , 2014, World Journal of Urology.

[13]  K. Ağras,et al.  Comparing the effectiveness of intranasal desmopressin and doxazosin in men with nocturia: a pilot randomized clinical trial. , 2013, Urology journal.

[14]  E. Sahin,et al.  The effect of combined therapy with tamsulosin hydrochloride and meloxicam in patients with benign prostatic hyperplasia symptoms and impact on nocturia and sleep quality. , 2013, International braz j urol : official journal of the Brazilian Society of Urology.

[15]  R. Dmochowski,et al.  Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. , 2013, The Journal of urology.

[16]  A. Malhotra,et al.  Efficacy and safety of flexible dose fesoterodine in men and women with overactive bladder symptoms including nocturnal urinary urgency. , 2013, The Journal of urology.

[17]  O. Yamaguchi,et al.  A phase II dose-ranging study of mirabegron in patients with overactive bladder , 2013, International Urogynecology Journal.

[18]  O. Yamaguchi,et al.  Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo‐controlled trial , 2013, BJU international.

[19]  R. Dmochowski,et al.  A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis. , 2012, European urology.

[20]  T. Tammela,et al.  [Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe]. , 2012, Urologiia.

[21]  G. Geirsson,et al.  A parallel, randomized, double-blind, placebo-controlled study to investigate the effect of SagaPro on nocturia in men , 2012, Scandinavian journal of urology.

[22]  O. Ogawa,et al.  Furosemide versus Gosha‐Jinki‐Gan, a Blended Herbal Medicine, for Nocturnal Polyuria: A Randomized Crossover Trial , 2012, Lower urinary tract symptoms.

[23]  J. Nørgaard,et al.  Desmopressin orally disintegrating tablet effectively reduces nocturia: Results of a randomized, double‐blind, placebo‐controlled trial , 2012, Neurourology and urodynamics.

[24]  Chien-Hsing Chang,et al.  Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study. , 2011, The Journal of urology.

[25]  H. Kakizaki,et al.  Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: impact on sleep evaluated by bladder diary. , 2011, The Journal of urology.

[26]  O. Yokoyama,et al.  Propiverine hydrochloride in Japanese patients with overactive bladder: A randomized, double‐blind, placebo‐controlled trial , 2011, International journal of urology : official journal of the Japanese Urological Association.

[27]  Choal Hee Park,et al.  Long-Term Effect of Loxoprofen Sodium on Nocturia in Patients with Benign Prostatic Hyperplasia , 2011, Korean journal of urology.

[28]  B. Rezakhaniha,et al.  Efficacy of desmopressin in treatment of nocturia in elderly men , 2011, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[29]  M. Drake,et al.  Nocturia as a manifestation of systemic disease , 2011, BJU international.

[30]  A. Papatsoris,et al.  Tamsulosin versus transurethral resection of the prostate: Effect on nocturia as a result of benign prostatic hyperplasia , 2011, International journal of urology : official journal of the Japanese Urological Association.

[31]  Hugh J. Lavery,et al.  Reducing nocturia in the elderly: A randomized placebo‐controlled trial of staggered furosemide and desmopressin , 2011, Neurourology and urodynamics.

[32]  J. J. de la Rosette,et al.  The role of nocturia in the quality of life of men with lower urinary tract symptoms , 2010, BJU international.

[33]  T. Miki,et al.  Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia with special reference to the storage symptom: A prospective randomized controlled study , 2008, International journal of urology : official journal of the Japanese Urological Association.

[34]  S. Falahatkar,et al.  Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study. , 2008, Urology.

[35]  C. Roehrborn,et al.  The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. , 2007, The Journal of urology.

[36]  H. Kakizaki,et al.  Randomized, double‐blind, placebo‐ and propiverine‐controlled trial of the once‐daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder , 2007, BJU international.

[37]  J. Thüroff,et al.  Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study. , 2007, European urology.

[38]  C. Roehrborn,et al.  Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia. , 2006, Urology.

[39]  J. Weiss,et al.  Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. , 2006, Urology.

[40]  D. Neilson,et al.  Diclofenac for treatment of nocturia caused by nocturnal polyuria: a prospective, randomised, double-blind, placebo-controlled crossover study. , 2006, European urology.

[41]  B. Djavan,et al.  The Impact of Tamsulosin Oral Controlled Absorption System (OCAS) on Nocturia and the Quality of Sleep: Preliminary Results of a Pilot Study , 2005 .

[42]  M. Drake,et al.  Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. , 2004, The Journal of urology.

[43]  M. Kutner,et al.  Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial. , 2003, The Journal of urology.

[44]  J. Donovan,et al.  The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society , 2002, BJU international.

[45]  P. Abrams,et al.  Efficacy of desmopressin in the treatment of nocturia: a double‐blind placebo‐controlled study in men , 2002, BJU international.

[46]  Magnus Fall,et al.  The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. , 2003, Urology.

[47]  Cannon,et al.  Desmopressin in the treatment of nocturnal polyuria in the male , 1999, BJU international.

[48]  Sundberg,et al.  Oral desmopressin for nocturnal polyuria in elderly subjects: a double‐blind, placebo‐controlled randomized exploratory study , 1999, BJU international.

[49]  P. Abrams,et al.  A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. , 1998, British journal of urology.

[50]  P. Johansen,et al.  Prophylactic treatment of adult nocturia with bumetanide. , 1988, British journal of urology.

[51]  S. Herschorn,et al.  Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. , 2013, The Journal of urology.

[52]  K. Fujikawa,et al.  Human atrial natriuretic peptide is a useful criterion in treatment of nocturia. , 2001, Scandinavian journal of urology and nephrology.